1. Home
  2. WBX vs ELOX Comparison

WBX vs ELOX Comparison

Compare WBX & ELOX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Wallbox N.V.

WBX

Wallbox N.V.

HOLD

Current Price

$3.72

Market Cap

53.4M

ML Signal

HOLD

ELOX

Eloxx Pharmaceuticals Inc. Common Stock

N/A

Current Price

$0.00

Market Cap

43.8M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
WBX
ELOX
Founded
2015
N/A
Country
Spain
United States
Employees
696
7
Industry
Industrial Specialties
Sector
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
53.4M
43.8M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
WBX
ELOX
Price
$3.72
N/A
Analyst Decision
Buy
Analyst Count
4
0
Target Price
$4.75
N/A
AVG Volume (30 Days)
102.5K
N/A
Earning Date
05-06-2026
N/A
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$18.10
N/A
Revenue Next Year
$94.11
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.29
N/A
52 Week High
$7.83
N/A

Technical Indicators

Market Signals
Indicator
WBX
ELOX
Relative Strength Index (RSI) 65.92 N/A
Support Level $3.70 N/A
Resistance Level $3.97 N/A
Average True Range (ATR) 0.33 0.00
MACD 0.10 0.00
Stochastic Oscillator 80.69 0.00

Price Performance

Historical Comparison
WBX
ELOX

About WBX Wallbox N.V.

Wallbox NV is a smart electric vehicle charging and energy management company. It creates a smart charging system combining technology design that manages the communication between the user, vehicle, grid, building, and charger. The company designs, manufactures, and distributes faster, simpler EV charging solutions for residential, business, and public use. Its smart charging product portfolio includes Level 2 alternating current chargers for home and business applications and direct current fast chargers for public applications. The company has three reportable operating segments: Europe, the Middle East and Asia (EMEA), its key revenue-generating segment, North America, and Asia-Pacific.

About ELOX Eloxx Pharmaceuticals Inc. Common Stock

Eloxx Pharmaceuticals Inc is a clinical-stage biopharmaceutical company engaged in developing novel, small-molecule product candidates designed to modulate the ribosome and promote readthrough of premature stop codons induced by nonsense mutations (NMs) to enable the production of full-length proteins. The exaluren, the company's investigational drug product for the treatment of rare kidney diseases, and, through the collaboration with Almirall, S.A. (Almirall), ZKN-013 for the treatment of rare skin diseases.

Share on Social Networks: